Eurosurveillance

From WikiMD's WELLNESSPEDIA

Eurosurveillance



DisciplineEpidemiology, Public Health
LanguageEnglish
Edited by
PublisherEuropean Centre for Disease Prevention and Control (European Union)
History1995–present
Frequency
Open accessYes
License
Impact factor
ISSN1560-7917



Eurosurveillance is a peer-reviewed open access medical journal that focuses on the field of epidemiology and public health. It is published by the European Centre for Disease Prevention and Control (ECDC), an agency of the European Union. The journal was established in 1995 and has been providing timely and reliable information on communicable diseases and public health issues ever since.

Scope and Content[edit]

Eurosurveillance covers a wide range of topics related to infectious diseases, including surveillance, prevention, and control. The journal publishes articles on the epidemiology of infectious diseases, outbreak investigations, and the evaluation of public health interventions. It serves as a platform for the dissemination of information on emerging infectious diseases and provides insights into the public health challenges faced by countries in the European region and beyond.

Publication and Access[edit]

The journal is published weekly and is available online as an open access resource, allowing researchers, public health professionals, and policymakers to access its content freely. This aligns with the ECDC's mission to provide high-quality information to support public health decision-making and action.

Editorial Process[edit]

Eurosurveillance employs a rigorous peer-review process to ensure the quality and reliability of the articles it publishes. The editorial board consists of experts in the fields of epidemiology, public health, and infectious diseases, who work to maintain the journal's high standards.

Impact and Recognition[edit]

Eurosurveillance is recognized as a leading journal in the field of public health and epidemiology. It is widely cited by researchers and has a significant impact on the development of public health policies and practices in Europe and globally.

External Links[edit]

See Also[edit]

References[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Eurosurveillance&oldid=6079773"